Loading
Latest filing published 01 Apr 2026 for 비씨월드제약, €14k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
홍영기 (senior executive) discloses dealings in 비씨월드제약 to DART (FSS). We count 8 filings; the first trade dates from 30 August 2022 and the latest from 26 March 2026.
The open-market record is one-sided, with 3 purchases worth €14k and not one sale. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
On 1 April 2026 came the latest disclosure, an open-market purchase for €14k in 비씨월드제약. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations